AC2993 28-Day Profile in Type 2 DiabetesPotent Glucose-Lowering with No Weight Gain
- All subjects responded to AC2993
- No severe hypoglycemia observed
- Adverse events reduced with dose escalation
Additional Phase 2 observations
AC2993 BID (at breakfast and dinner) N=26
Note: 28-day results may underestimate total effect on HbA1c and body weight
* Statistically different from placebo
As reported at ADA in June 2001